{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:17:46Z","timestamp":1793261866196,"version":"4.5.0"},"reference-count":174,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD), a prevalent metabolic disorder, is increasingly recognized as a complex condition influenced by gut microbiota dysbiosis. However, the heterogeneity in findings across studies has hindered the clinical translation of microbiota-based interventions. In this narrative review, we synthesize current evidence on gut microbial alterations in patients with NAFLD, with a focus on the sources of variability that contribute to inconsistent results. We included human studies (2000\u20132024) that compared gut microbiota profiles between NAFLD patients and healthy controls using 16S rRNA or metagenomic sequencing; key drivers of microbial changes include clinical factors (metabolic comorbidities, disease progression), biological variables (diet, genetics), and methodological biases (sequencing platform differences, diagnostic criteria variability). Emerging evidence highlights the role of non-bacterial components (fungi, viruses) in modulating bacterial communities and disrupting host metabolic pathways, exacerbating hepatic inflammation and lipid accumulation. To overcome current limitations, we propose integrating multi-omics approaches (metagenomics, metabolomics, and proteomics) with a longitudinal study design to capture dynamic microbiota\u2013host interactions. Precision microbiota therapies, including strain-specific probiotics, engineered microbial consortia, and fecal microbiota transplantation tailored to individual dysbiosis profiles, are emerging as promising strategies for targeted interventions. Addressing these challenges is essential to identifying reliable microbial biomarkers and developing personalized strategies for NAFLD prevention and treatment. Future research should harmonize methodologies, validate causal mechanisms, and optimize microbiota-based therapies to bridge experimental findings and clinical application.<\/jats:p>","DOI":"10.3389\/fmicb.2025.1645298","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:35:43Z","timestamp":1760528143000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Gut microbiota heterogeneity in non-alcoholic fatty liver disease: a narrative review of drivers, mechanisms, and clinical relevance"],"prefix":"10.3389","volume":"16","author":[{"given":"Ying","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naisi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/medicina58111559","article-title":"Fecal microbiota transplantation in NAFLD treatment","volume":"58","author":"Abenavoli","year":"2022","journal-title":"Medicina"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.3390\/nu12123770","article-title":"Food timing, circadian rhythm and chrononutrition: a systematic review of time-restricted eating's effects on human health","volume":"12","author":"Adafer","year":"2020","journal-title":"Nutrients"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.cgh.2018.01.026","article-title":"Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis","volume":"16","author":"Ajmera","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/hep.31417","article-title":"Microbiomics, metabolomics, predicted metagenomics, and hepatic steatosis in a population-based study of 1,355 adults","volume":"73","author":"Alferink","year":"2021","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1055\/s-0041-1730927","article-title":"Insights into nonalcoholic fatty-liver disease heterogeneity","volume":"41","author":"Arrese","year":"2021","journal-title":"Semin. Liver Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e98019","DOI":"10.1172\/jci.insight.98019","article-title":"Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis","volume":"3","author":"Bajaj","year":"2018","journal-title":"JCI Insight"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0194171","DOI":"10.1371\/journal.pone.0194171","article-title":"Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease","volume":"13","author":"Barengolts","year":"2018","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.rcl.2024.07.003","article-title":"Multiparametric ultrasound for chronic liver disease","volume":"63","author":"Barr","year":"2025","journal-title":"Radiol. Clin. North Am."},{"key":"B10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2331460","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in metabolic-associated steatotic liver disease (MASLD)","volume":"16","author":"Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/nu14050941","article-title":"A comparison of dietary patterns and factors influencing food choice among ethnic groups living in one locality: a systematic review","volume":"14","author":"Bennett","year":"2022","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41575-023-00792-1","article-title":"Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology","volume":"20","author":"Bolshette","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/nu14091773","article-title":"A low glycemic index mediterranean diet combined with aerobic physical activity rearranges the gut microbiota signature in NAFLD patients","volume":"14","author":"Calabrese","year":"2022","journal-title":"Nutrients"},{"key":"B16","doi-asserted-by":"publisher","first-page":"101547","DOI":"10.1016\/j.eclinm.2022.101547","article-title":"Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"51","author":"Cao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"25808","DOI":"10.1073\/pnas.1912359116","article-title":"Alcohol shifts gut microbial networks and ameliorates a murine model of neuroinflammation in a sex-specific pattern","volume":"116","author":"Caslin","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1136\/gutjnl-2019-318424","article-title":"Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial","volume":"68","author":"Chambers","year":"2019","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","first-page":"604919","DOI":"10.3389\/fmed.2020.604919","article-title":"Cigarette smoking increased risk of overall mortality in patients with non-alcoholic fatty liver disease: a nationwide population-based cohort study","volume":"7","author":"Charatcharoenwitthaya","year":"2020","journal-title":"Front. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41586-022-05299-4","article-title":"Gut bacteria alleviate smoking-related NASH by degrading gut nicotine","volume":"610","author":"Chen","year":"2022","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"105110","DOI":"10.1016\/j.ebiom.2024.105110","article-title":"Sedentary lifestyle, physical activity, and gastrointestinal diseases: evidence from mendelian randomization analysis","volume":"103","author":"Chen","year":"2024","journal-title":"EBioMedicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0197923","DOI":"10.1128\/spectrum.01979-23","article-title":"Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota","volume":"12","author":"Chen","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/ajcn\/nqy358","article-title":"Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial","volume":"109","author":"Chen","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"34055","DOI":"10.1038\/srep34055","article-title":"Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/MEG.0b013e328328f3ec","article-title":"Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients","volume":"21","author":"Cotrim","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2295429","DOI":"10.1080\/19490976.2023.2295429","article-title":"Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction","volume":"16","author":"Cross","year":"2024","journal-title":"Gut Microbes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s42255-024-01021-y","article-title":"Maternal circadian rhythm disruption affects neonatal inflammation via metabolic reprograming of myeloid cells","volume":"6","author":"Cui","year":"2024","journal-title":"Nat. Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","article-title":"Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology","volume":"65","author":"Dao","year":"2016","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2337\/dc16-1324","article-title":"Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut","volume":"40","author":"de la Cuesta-Zuluaga","year":"2017","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/19490976.2015.1107696","article-title":"A dysbiotic subpopulation of alcohol-dependent subjects","volume":"6","author":"de Timary","year":"2015","journal-title":"Gut Microbes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jhep.2021.11.029","article-title":"The fecal mycobiome in non-alcoholic fatty liver disease","volume":"76","author":"Demir","year":"2022","journal-title":"J. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010194","article-title":"Detailed molecular mechanisms involved in drug-induced non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: an update","author":"Di Pasqua","year":"2022","journal-title":"Biomedicines"},{"key":"B34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern. Emerg. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2167170","DOI":"10.1080\/19490976.2023.2167170","article-title":"Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease","volume":"15","author":"Dong","year":"2023","journal-title":"Gut Microbes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1530\/EJE-18-0826","article-title":"Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial","volume":"180","author":"Ejtahed","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.tjnut.2023.05.019","article-title":"Probiotic supplementation, hepatic fibrosis, and the microbiota profile in patients with nonalcoholic steatohepatitis: a randomized controlled trial","volume":"153","author":"Escouto","year":"2023","journal-title":"J. Nutr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.radi.2024.07.006","article-title":"Ultrasound screening of paediatric non-alcoholic fatty liver disease (NAFLD): a critical literature review","volume":"30","author":"Ezenwuba","year":"2024","journal-title":"Radiography"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0263931","DOI":"10.1371\/journal.pone.0263931","article-title":"Lifestyle changes in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"17","author":"Fern\u00e1ndez","year":"2022","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature23292","article-title":"The evolution of the host microbiome as an ecosystem on a leash","volume":"548","author":"Foster","year":"2017","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12967-022-03799-5","article-title":"Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study","volume":"21","author":"Gagnon","year":"2023","journal-title":"J Nutr. Transl. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"110665","DOI":"10.1016\/j.brainresbull.2023.110665","article-title":"Sex and gender as critical and distinct contributors to the human brain-gut-microbiome axis","volume":"199","author":"Gancz","year":"2023","journal-title":"Brain Res. Bull."},{"key":"B43","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jhep.2024.05.008","article-title":"Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD","volume":"81","author":"Gawrieh","year":"2024","journal-title":"J. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/dom.14891","article-title":"Effect of faecal microbial transplant via colonoscopy in patients with severe obesity and insulin resistance: a randomized double-blind, placebo-controlled Phase 2 trial","volume":"25","author":"Ghorbani","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41575-022-00605-x","article-title":"The gut microbiome as a modulator of healthy ageing","volume":"19","author":"Ghosh","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.apsb.2021.12.011","article-title":"Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases","volume":"12","author":"Guan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.3748\/wjg.v19.i32.5393","article-title":"Favorable effect of modest alcohol consumption to fatty liver disease","volume":"19","author":"Hamaguchi","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3350\/cmh.2023.0155","article-title":"Non-alcoholic fatty liver disease: definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0154090","DOI":"10.1371\/journal.pone.0154090","article-title":"Intestinal microbiota is influenced by gender and body mass index","volume":"11","author":"Haro","year":"2016","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/jgh.12786","article-title":"Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study","volume":"30","author":"Hashimoto","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"716783","DOI":"10.3389\/fnut.2021.716783","article-title":"Dietary interventions in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"8","author":"Houttu","year":"2021","journal-title":"Front. Nutr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","article-title":"The microbiota and the gut-liver axis in primary sclerosing cholangitis","volume":"20","author":"Hov","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1097\/HEP.0000000000000238","article-title":"Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome","volume":"77","author":"Hsu","year":"2023","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors","volume":"20","author":"Huang","year":"","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B56","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","article-title":"Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study","volume":"165","author":"Huang","year":"","journal-title":"Gastroenterology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"693507","DOI":"10.3389\/fmed.2021.693507","article-title":"NAFLD or MAFLD: which has closer association with all-cause and cause-specific mortality?-results from NHANES III","volume":"8","author":"Huang","year":"2021","journal-title":"Front. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"102420","DOI":"10.1016\/j.jceh.2024.102420","article-title":"Comparison of NAFLD, MAFLD, and MASLD prevalence and clinical characteristics in Asia adults","volume":"15","author":"Huang","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1107071","DOI":"10.3389\/fendo.2022.1107071","article-title":"The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial","volume":"13","author":"Hui","year":"2022","journal-title":"Front. Endocrinol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1965463","DOI":"10.1080\/19490976.2021.1965463","article-title":"Associations of the gut microbiome with hepatic adiposity in the multiethnic cohort adiposity phenotype study","volume":"13","author":"Hullar","year":"2021","journal-title":"Gut Microbes"},{"key":"B61","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3350\/cmh.2020.0067","article-title":"Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH","volume":"26","author":"Hydes","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"B63","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"key":"B64","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/jamainternmed.2023.8029","article-title":"Outcomes of various classes of oral antidiabetic drugs on nonalcoholic fatty liver disease","volume":"184","author":"Jang","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e1003100","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","article-title":"Long-term impacts of antibiotic exposure on the human intestinal microbiota","volume":"156","author":"Jernberg","year":"2010","journal-title":"Microbiology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13073-022-01053-7","article-title":"Gut microbiota predicts body fat change following a low-energy diet: a PREVIEW intervention study","volume":"14","author":"Jian","year":"2022","journal-title":"Genome Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"111321","DOI":"10.1016\/j.celrep.2022.111321","article-title":"Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice","volume":"40","author":"Kabbani","year":"2022","journal-title":"Cell Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12876-015-0330-2","article-title":"Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing","volume":"15","author":"Kasai","year":"2015","journal-title":"BMC Gastroenterol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molmet.2019.01.012","article-title":"Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice","volume":"22","author":"Ke","year":"2019","journal-title":"Mol. Metab."},{"key":"B71","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2024.01.001","article-title":"Gut-liver axis calibrates intestinal stem cell fitness","volume":"187","author":"Kim","year":"2024","journal-title":"Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S2213-8587(22)00033-X","article-title":"Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study","volume":"10","author":"Kivim\u00e4ki","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"10410","DOI":"10.1038\/ncomms10410","article-title":"Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children","volume":"7","author":"Korpela","year":"2016","journal-title":"Nat. Commun."},{"key":"B74","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCRESAHA.123.323520","article-title":"Circadian rhythms in cardiovascular metabolism","volume":"134","author":"Lal","year":"2024","journal-title":"Circ. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/j.gastro.2020.07.005","article-title":"Intestinal virome signature associated with severity of nonalcoholic fatty liver disease","volume":"159","author":"Lang","year":"2020","journal-title":"Gastroenterology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"104952","DOI":"10.1016\/j.ebiom.2023.104952","article-title":"Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid","volume":"100","author":"Lau","year":"2024","journal-title":"EBioMedicine"},{"key":"B77","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/jcm7090282","article-title":"Association between cigarette smoking status and composition of gut microbiota: population-based cross-sectional study","volume":"7","author":"Lee","year":"2018","journal-title":"J. Clin. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e2030415","DOI":"10.1001\/jamanetworkopen.2020.30415","article-title":"Effects of fecal microbiome transfer in adolescents with obesity: the gut bugs randomized controlled trial","volume":"3","author":"Leong","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B79","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jare.2024.03.004","article-title":"Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: a review","volume":"68","author":"Li","year":"2025","journal-title":"J. Adv. Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40168-021-01086-x","article-title":"Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype","volume":"9","author":"Li","year":"2021","journal-title":"Microbiome"},{"key":"B81","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.3390\/nu15214554","article-title":"Eight weeks of Bifidobacterium lactis BL-99 supplementation improves lipid metabolism and sports performance through short-chain fatty acids in cross-country skiers: a preliminary study","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients"},{"key":"B82","doi-asserted-by":"publisher","first-page":"155398","DOI":"10.1016\/j.phymed.2024.155398","article-title":"Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial","volume":"130","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"B83","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2188\/jea.JE20120067","article-title":"Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China","volume":"23","author":"Liu","year":"2013","journal-title":"J. Epidemiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/hep.31523","article-title":"The commensal microbe veillonella as a marker for response to an FGF19 analog in NASH","volume":"73","author":"Loomba","year":"2021","journal-title":"Hepatology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell. Metab."},{"key":"B86","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cmet.2019.08.002","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"30","author":"Loomba","year":"2019","journal-title":"Cell Metab."},{"key":"B87","doi-asserted-by":"publisher","author":"Lu","year":"2024","DOI":"10.3390\/foods13182992"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1520158","DOI":"10.3389\/fphar.2024.1520158","article-title":"Therapeutic effects of composite probiotics derived from fermented camel milk on metabolic dysregulation and intestinal barrier integrity in type 2 diabetes rats","volume":"15","author":"Manaer","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jhep.2021.12.035","article-title":"A disease-promoting role of the intestinal mycobiome in non-alcoholic fatty liver disease","volume":"76","author":"Mehal","year":"2022","journal-title":"J. Hepatol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.scib.2023.01.023","article-title":"The gut microbiome and nicotine metabolism in NAFLD","volume":"68","author":"Miao","year":"2023","journal-title":"Sci. Bull."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/antiox13121532","article-title":"Interplay of oxidative stress, gut microbiota, and nicotine in metabolic-associated steatotic liver disease (MASLD)","volume":"13","author":"Mignini","year":"2024","journal-title":"Antioxidants"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41591-021-01399-2","article-title":"Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial","volume":"27","author":"Mocanu","year":"2021","journal-title":"Nat. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/gutjnl-2020-321643","article-title":"Metagenomics analysis of gut microbiota in response to diet intervention and gestational diabetes in overweight and obese women: a randomised, double-blind, placebo-controlled clinical trial","volume":"70","author":"Mokkala","year":"2021","journal-title":"Gut"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e3575","DOI":"10.1210\/clinem\/dgaa382","article-title":"Effect of gut microbiota and PNPLA3 rs738409 variant on nonalcoholic fatty liver disease (NAFLD) in obese youth","volume":"105","author":"Monga Kravetz","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B95","doi-asserted-by":"publisher","first-page":"318","DOI":"10.24875\/BMHIM.22000008","article-title":"Gut microbiota composition after a dietary and physical activity intervention: a pilot study in Mexican children with obesity","volume":"79","author":"Mor\u00e1n-Ramos","year":"2022","journal-title":"Bol. Med. Hosp. Infant Mex."},{"key":"B96","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/dc20-2257","article-title":"Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial","volume":"44","author":"Mueller","year":"2021","journal-title":"Diabetes Care"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/ijc.30818","article-title":"The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: a study in the Swedish AMORIS cohort","volume":"141","author":"Nderitu","year":"2017","journal-title":"Int. J. Cancer"},{"key":"B99","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e70023","DOI":"10.1111\/liv.70023","article-title":"Gut microbiota predicts treatment response to empagliflozin among MASLD patients without diabetes mellitus","volume":"45","author":"Ng","year":"2025","journal-title":"Liver Int."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.cmet.2023.08.002","article-title":"Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations","volume":"35","author":"Ni","year":"2023","journal-title":"Cell Metab."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.csbj.2020.09.026","article-title":"A metagenome-wide association study of gut microbiome and visceral fat accumulation","volume":"18","author":"Nie","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e2000030","DOI":"10.1002\/mnfr.202000030","article-title":"Impact of extreme obesity and diet-induced weight loss on the fecal metabolome and gut microbiota","volume":"65","author":"Nogacka","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/nu13061805","article-title":"The effect of dietary fibre on gut microbiota, lipid profile, and inflammatory markers in patients with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials","volume":"13","author":"Ojo","year":"2021","journal-title":"Nutrients"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/ceh.2024.136220","article-title":"Biological rhythms of the liver","volume":"10","author":"Panasiuk","year":"2024","journal-title":"Clin. Exp. Hepatol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0041-1742279","article-title":"The role of liver zonation in physiology, regeneration, and disease","volume":"42","author":"Panday","year":"2022","journal-title":"Semin Liver Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5009\/gnl230044","article-title":"Genetic and metabolic characteristics of lean nonalcoholic fatty liver disease in a korean health examinee cohort","volume":"18","author":"Park","year":"2024","journal-title":"Gut Liver"},{"key":"B108","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12866-021-02215-0","article-title":"Comprehensive analysis of gut microbiota of a healthy population and covariates affecting microbial variation in two large Japanese cohorts","volume":"21","author":"Park","year":"2021","journal-title":"BMC Microbiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"111117","DOI":"10.1016\/j.biopha.2020.111117","article-title":"Evaluation of the gut microbiota after metformin intervention in children with obesity: a metagenomic study of a randomized controlled trial","volume":"134","author":"Pastor-Villaescusa","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1073\/pnas.1916539117","article-title":"In pancreatic islets from type 2 diabetes patients, the dampened circadian oscillators lead to reduced insulin and glucagon exocytosis","volume":"117","author":"Petrenko","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.3390\/nu16172838","article-title":"Interactions between gut microbiota and natural bioactive polysaccharides in metabolic diseases: review","volume":"16","author":"Pi","year":"2024","journal-title":"Nutrients"},{"key":"B112","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","article-title":"Sarcopenic obesity in older adults: a clinical overview","volume":"20","author":"Prado","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41588-021-00991-z","article-title":"Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort","volume":"54","author":"Qin","year":"2022","journal-title":"Nat. Genet."},{"key":"B115","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","article-title":"Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease","volume":"11","author":"Raman","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2020.08.065","article-title":"Childhood development and the microbiome-the intestinal microbiota in maintenance of health and development of disease during childhood development","volume":"160","author":"Ronan","year":"2021","journal-title":"Gastroenterology"},{"key":"B118","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1210\/endrev\/bnad029","article-title":"Metformin, cognitive function, and changes in the gut microbiome","volume":"45","author":"Rosell-D\u00edaz","year":"2024","journal-title":"Endocr. Rev."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e2300631","DOI":"10.1002\/ardp.202300631","article-title":"Exosomal miR-122, miR-128, miR-200, miR-298, and miR-342 as novel diagnostic biomarkers in NAFL\/NASH: impact of LPS\/TLR-4\/FoxO3 pathway","volume":"357","author":"Samy","year":"2024","journal-title":"Arch. Pharm."},{"key":"B120","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat. Genet."},{"key":"B121","doi-asserted-by":"publisher","first-page":"e170998","DOI":"10.1172\/JCI170998","article-title":"Circadian disruption, clock genes, and metabolic health","volume":"134","author":"Schrader","year":"2024","journal-title":"J. Clin. Invest."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.3390\/nu14214695","article-title":"Indolepropionic acid, a gut bacteria-produced tryptophan metabolite and the risk of type 2 diabetes and non-alcoholic fatty liver disease","volume":"14","author":"Sehgal","year":"2022","journal-title":"Nutrients"},{"key":"B124","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3390\/microorganisms9102118","article-title":"Sex-specific associations between gut microbiome and non-alcoholic fatty liver disease among urban chinese adults","volume":"9","author":"Shi","year":"2021","journal-title":"Microorganisms"},{"key":"B126","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1210\/en.2013-1795","article-title":"Nicotine in combination with a high-fat diet causes intramyocellular mitochondrial abnormalities in male mice","volume":"155","author":"Sinha-Hikim","year":"2014","journal-title":"Endocrinology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1530\/REP-22-0303","article-title":"Sex, puberty, and the gut microbiome","volume":"165","author":"Sisk-Hackworth","year":"2023","journal-title":"Reproduction"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"key":"B129","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-3-030-28151-9_12","article-title":"The Kai-protein clock-keeping track of cyanobacteria's daily life","volume":"93","author":"Snijder","year":"2019","journal-title":"Subcell. Biochem."},{"key":"B130","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.cgh.2024.05.052","article-title":"Genetics of metabolic dysfunction-associated steatotic liver disease: the state of the art update","volume":"22","author":"Sookoian","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"e12956","DOI":"10.1111\/jpi.12956","article-title":"Circadian desynchrony and glucose metabolism","volume":"76","author":"Speksnijder","year":"2024","journal-title":"J. Pineal Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e4693","DOI":"10.7717\/peerj.4693","article-title":"Effects of tobacco smoke and electronic cigarette vapor exposure on the oral and gut microbiota in humans: a pilot study","volume":"6","author":"Stewart","year":"2018","journal-title":"PeerJ"},{"key":"B133","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/mco.2024.2798","article-title":"Factors associated with immune-related severe adverse events (Review)","volume":"22","author":"Su","year":"2025","journal-title":"Mol. Clin. Oncol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1053\/j.gastro.2022.11.017","article-title":"Guardian, intermediary, or perpetrator? New insights into environmental exposure, the gut microbiome, and nonalcoholic fatty liver disease","volume":"164","author":"Sun","year":"2023","journal-title":"Gastroenterology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/ph18010055","article-title":"The gut microbiota-related antihyperglycemic effect of metformin","volume":"18","author":"Szymczak-Pajor","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B137","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J. Hepatol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3748\/wjg.v27.i18.2160","article-title":"Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis","volume":"27","author":"Takayama","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.soard.2020.03.013","article-title":"Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review","volume":"16","author":"Talavera-Urquijo","year":"2020","journal-title":"Surg. Obes. Relat. Dis"},{"key":"B140","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/metabo12060514","article-title":"Interactions between tryptophan metabolism, the gut microbiome and the immune system as potential drivers of non-alcoholic fatty liver disease (NAFLD) and metabolic diseases","volume":"12","author":"Teunis","year":"2022","journal-title":"Metabolites"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/gutjnl-2023-330584","article-title":"Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers","volume":"73","author":"Trebicka","year":"2024","journal-title":"Gut"},{"key":"B143","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomolecules"},{"key":"B144","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/jn\/nxaa312","article-title":"Minor changes in the composition and function of the gut microbiota during a 12-week whole grain wheat or refined wheat intervention correlate with liver fat in overweight and obese adults","volume":"151","author":"van Trijp","year":"2021","journal-title":"J. Nutr."},{"key":"B145","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-020-2269-x","article-title":"Statin therapy is associated with lower prevalence of gut microbiota dysbiosis","volume":"581","author":"Vieira-Silva","year":"2020","journal-title":"Nature"},{"key":"B146","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jmri.29086","article-title":"Application of intravoxel incoherent motion in clinical liver imaging: a literature review","volume":"60","author":"Wang","year":"2024","journal-title":"J. Magn. Reson. Imaging"},{"key":"B147","doi-asserted-by":"publisher","first-page":"822190","DOI":"10.3389\/fmed.2022.822190","article-title":"Oral and gut microbial dysbiosis and non-alcoholic fatty liver disease: the central role of Porphyromonas gingivalis","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"e0232630","DOI":"10.1371\/journal.pone.0232630","article-title":"Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS One"},{"key":"B149","doi-asserted-by":"publisher","first-page":"568","DOI":"10.20524\/aog.2021.0612","article-title":"Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"34","author":"Wijarnpreecha","year":"2021","journal-title":"Ann. Gastroenterol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"e62885","DOI":"10.1371\/journal.pone.0062885","article-title":"Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis\u2013a longitudinal study","volume":"8","author":"Wong","year":"2013","journal-title":"PLoS One"},{"key":"B151","doi-asserted-by":"publisher","first-page":"744713","DOI":"10.3389\/fmed.2021.744713","article-title":"The effects of modest alcohol consumption on non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"8","author":"Wongtrakul","year":"2021","journal-title":"Front. Med."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.14309\/ajg.0000000000001141","article-title":"Childhood and adulthood passive smoking and nonalcoholic fatty liver in midlife: a 31-year cohort study","volume":"116","author":"Wu","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s12072-023-10622-w","article-title":"The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK\/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease","volume":"18","author":"Wu","year":"2024","journal-title":"Hepatol. Int."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1038\/ismej.2016.37","article-title":"Cigarette smoking and the oral microbiome in a large study of American adults","volume":"10","author":"Wu","year":"2016","journal-title":"ISME J."},{"key":"B155","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s13238-020-00814-7","article-title":"The role of the gut microbiome and its metabolites in metabolic diseases","volume":"12","author":"Wu","year":"2021","journal-title":"Protein Cell"},{"key":"B156","doi-asserted-by":"publisher","first-page":"2221450","DOI":"10.1080\/19490976.2023.2221450","article-title":"Resynchronized rhythmic oscillations of gut microbiota drive time-restricted feeding induced nonalcoholic steatohepatitis alleviation","volume":"15","author":"Xia","year":"2023","journal-title":"Gut Microbes"},{"key":"B157","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1007\/s00210-023-02492-8","article-title":"Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiota","volume":"396","author":"Xu","year":"2023","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"e13724","DOI":"10.1111\/obr.13724","article-title":"Inflammation-mediated metabolic regulation in adipose tissue","volume":"25","author":"Xu","year":"2024","journal-title":"Obes. Rev."},{"key":"B159","doi-asserted-by":"publisher","first-page":"759306","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: a randomized clinical trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12967-024-04996-0","article-title":"Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease","volume":"22","author":"Yan","year":"2024","journal-title":"J. Transl. Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"823262","DOI":"10.3389\/fcimb.2021.823262","article-title":"Gut microbiome alterations in patients with visceral obesity based on quantitative computed tomography","volume":"11","author":"Yan","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1097853","DOI":"10.3389\/fimmu.2022.1097853","article-title":"Mechanismbased role of the intestinal microbiota in gestational diabetes mellitus: a systematic review and meta-analysis","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Immunol."},{"key":"B163","first-page":"988","article-title":"Effectiveness of Jiedu granule on gut microbiota in patients with advanced hepatocellular carcinoma: a randomized controlled trial","volume":"42","author":"Yifu","year":"2022","journal-title":"J. Tradit. Chin. Med."},{"key":"B164","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41065-024-00328-w","article-title":"Correlation between gut microbiota characteristics and non-small cell lung cancer based on macrogenomics sequencing","volume":"161","author":"Zeng","year":"2024","journal-title":"Hereditas"},{"key":"B165","doi-asserted-by":"publisher","first-page":"16219","DOI":"10.1073\/pnas.1408886111","article-title":"A circadian gene expression atlas in mammals: implications for biology and medicine","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29081859","article-title":"A systematic review of statins for the treatment of nonalcoholic steatohepatitis: safety, efficacy, and mechanism of action","author":"Zhang","year":"2024","journal-title":"Molecules"},{"key":"B167","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"B168","doi-asserted-by":"publisher","first-page":"2345134","DOI":"10.1080\/19490976.2024.2345134","article-title":"Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial","volume":"16","author":"Zhang","year":"2024","journal-title":"Gut Microbes"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China From 2008 to 2018: a systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"B170","doi-asserted-by":"publisher","first-page":"e33981","DOI":"10.1097\/MD.0000000000033981","article-title":"Statins on nonalcoholic fatty liver disease: a systematic review and meta-analysis of 14 RCTs","volume":"102","author":"Zhou","year":"2023","journal-title":"Medicine"},{"key":"B171","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.3390\/microorganisms11112628","article-title":"Integrated macrogenomics and metabolomics explore alterations and correlation between gut microbiota and serum metabolites in adult epileptic patients: a pilot study","volume":"11","author":"Zhou","year":"2023","journal-title":"Microorganisms"},{"key":"B172","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40168-024-01826-9","article-title":"Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome","volume":"12","author":"Zhou","year":"2024","journal-title":"Microbiome"},{"key":"B173","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejim.2024.01.013","article-title":"Non-invasive testing and risk-stratification in patients with MASLD","volume":"122","author":"Zoncap\u00e8","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"B174","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/nu12030631","article-title":"Effect of caloric restriction on bmi, gut microbiota, and blood amino acid levels in non-obese adults","volume":"12","author":"Zou","year":"2020","journal-title":"Nutrients"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1645298\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:35:45Z","timestamp":1760528145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1645298\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":174,"alternative-id":["10.3389\/fmicb.2025.1645298"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1645298","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1645298"}}